In today’s rapidly evolving biopharmaceutical landscape, success hinges on innovation, precision, and data-driven decision-making. As the industry continues to focus on research design and advanced data collection technologies, leveraging biostatistics has become a cornerstone of effective drug development.
At Techvignan, our experienced team of biostatisticians and statistical programmers delivers a collaborative and integrated approach to meet the statistical demands of every phase in the drug development lifecycle. We offer both operational support and strategic insights that are critical for regulatory success and scientific rigor.
We primarily serve pharmaceutical, biotechnology, and medical device companies involved in clinical research and drug development.
CDISC standards ensure that clinical data is structured and submitted in a way that regulatory bodies like the FDA and EMA can easily interpret, accelerating review and approval timelines.
We create interim analysis plans, perform statistical evaluations, and prepare data in formats required by DSMBs to ensure ongoing safety and efficacy monitoring.
Yes, we contribute to various regulatory documents, including CSRs, ISS/ISE, and DSURs, ensuring they meet global regulatory expectations.
Our team is proficient in industry-standard tools such as SAS and R, ensuring precision, compliance, and scalability across all statistical programming and analysis tasks.
Techvignan offers a wide range of CRO services designed to support clients throughout the drug development process.
Techvignan is your trusted partner for comprehensive, value-driven biopharmaceutical solutions. As an integrated service provider, we specialize in uniting science, technology, and strategy to accelerate drug development and commercialization.
